{
    "SPADE_UN_18815": {
        "Clinical Information": [],
        "Patent Information": [],
        "Sequence Information": {
            "SPADE ID": "SPADE_UN_18815",
            "Peptide Name": "DFT561 (Synthetic AMPs, DFT503 variant, Leu-rich; XXA, UCLL1c)",
            "Source": "Sequence shuffling, designed",
            "Family": "Not found",
            "Gene": "Not found",
            "Sequence": "GLKLLLSLGLKLL",
            "Sequence Length": 13,
            "UniProt Entry": "Ref",
            "Protein Existence": "Not found",
            "Biological Activity": [
                "Anti-Gram+",
                "Anti-MRSA"
            ],
            "Target Organism": "Not found",
            "Hemolytic Activity": "Not found",
            "Cytotoxicity": "Not found",
            "Binding Target": "Not found",
            "Linear/Cyclic": "Not found",
            "N-terminal Modification": "Not found",
            "C-terminal Modification": "Not found",
            "Stereochemistry": "Not found",
            "Structure Description": "Not found",
            "Formula": "Not found",
            "Mass": 1380.8,
            "PI": 10.0,
            "Hydrophobicity": 1.62,
            "Half Life": "Not found",
            "Function": "Not found",
            "Literature": [
                {
                    "Author": "Mishra B, Lakshmaiah Narayana J, Lushnikova T, Wang X, Wang G. 2019",
                    "Reference": "Proc Natl Acad Sci U S A. 2019 Jul 2;116(27):13517-13522. doi: 10.1073/pnas.1821410116.PubMed",
                    "Title": "Low cationicity is important for systemic in vivo efficacy of database-derived peptides against drug-resistant Gram-positive pathogens"
                }
            ],
            "Frequent Amino Acids": "LGK",
            "Absent Amino Acids": "ACDEFHIMNOPQRTUVWY",
            "Basic Residues": 2,
            "Acidic Residues": 0,
            "Hydrophobic Residues": 8,
            "Polar Residues": 3,
            "Positive Residues": 2,
            "Negative Residues": 0,
            "Net Charge": 2,
            "Comments": "Sequence analysis: APD analysis reveals that this sequence is poorly similar (92.31%) toDFT503. L: 62%.Chemical modification:  C-terminal amidation.Activity: Active against S. aureus USA300 or M838-17 (MIC 1.56-3.1 uM), E. faecium V286-17  (MIC 3.1-6.25 uM) anti-VRE, P-aeruginosa PAO1 (MIC > 25 uM), E-coli ATCC 25922 (MIC> 25 uM), and K-pneumonia ATCC13883 (MIC > 25 uM).Toxicity:  human RBC HC50 >300 uM, much less hemo.lytic.MOA:bacteria:S. aureus: the peptide acted on bacterial membranes: permeabilization and depolarization.Structure:  NMR studies revealed helical structure bound to SDS micelles.Resistance development:no:bacteria:S. aureus USA300: S. aureus USA300 did not develop resistance to DFT561d (made of D-amino acids) in a multiple passage experiment after 14 passages while Nafcillin did.Animal model:mouse: DFT561 and DFT561d at 5 mg/kg showed similar systemic efficacy in neutropenic mice infected with MRSA (i.p./i.p.).Updated 8/2024",
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_UN_13694",
                    "Similarity": 1.0,
                    "Sequence": "LGLKLLWSAYKHRKTL"
                },
                {
                    "SPADE_ID": "SPADE_UN_25668",
                    "Similarity": 1.0,
                    "Sequence": "LGLKLLWSAYKHRKTI"
                },
                {
                    "SPADE_ID": "SPADE_UN_25669",
                    "Similarity": 1.0,
                    "Sequence": "LGLKLLWSAYKHRKTI"
                }
            ]
        }
    }
}